Drugs A-Z
Complete pharmaceutical drug database with pharmacological properties and clinical data.
Drugs A-Z
Complete pharmaceutical drug database with pharmacological properties and clinical data.
Browse the pages below for detailed information.
'1988
'1988. Synthetic organic pharmaceutical agent.
'2882
'2882. Synthetic organic pharmaceutical agent.
'9213
'9213. Synthetic organic pharmaceutical agent.
(-)-(R)-efonidipine
(-)-(R)-efonidipine. Synthetic organic pharmaceutical agent.
(-)-α-thujone
(-)-α-thujone. Natural product pharmaceutical agent.
(-)-adrenaline
(-)-adrenaline. Metabolite pharmaceutical agent.
(-)-bremazocine
(-)-bremazocine. Synthetic organic pharmaceutical agent.
(-)-cyclazocine
(-)-cyclazocine. Synthetic organic pharmaceutical agent.
(-)-devapamil
(-)-devapamil. Synthetic organic pharmaceutical agent.
(-)-englerin A
(-)-englerin A. Synthetic organic pharmaceutical agent.
(-)-Epicatechin
(-)-Epicatechin. Natural product pharmaceutical agent.
(-)-HIP-A
(-)-HIP-A. Synthetic organic pharmaceutical agent.
(-)-isatispironeol A
(-)-isatispironeol A. Natural product pharmaceutical agent.
(-)-menthol
(-)-menthol. Natural product pharmaceutical agent.
(-)-N-porphynorapomorphine
(-)-N-porphynorapomorphine. Synthetic organic pharmaceutical agent.
(-)-trans-H2-PAT
(-)-trans-H2-PAT. Synthetic organic pharmaceutical agent.
(+)-4 enantiomer [PMID: 39046805]
(+)-4 enantiomer [PMID: 39046805]. Synthetic organic pharmaceutical agent.
(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid
(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid. Synthetic organic pharmaceutical agent.
(+)-ADTN
(+)-ADTN. Synthetic organic pharmaceutical agent.
(+)-AJ76
(+)-AJ76. Synthetic organic pharmaceutical agent.
(+)-benzphetamine
(+)-benzphetamine. Synthetic organic pharmaceutical agent.
(+)-BHFF
(+)-BHFF. Synthetic organic pharmaceutical agent.
(+)-butaclamol
(+)-butaclamol. Synthetic organic pharmaceutical agent.
(+)-cis-H2-PAT
(+)-cis-H2-PAT. Synthetic organic pharmaceutical agent.
(+)-cyclazosin
(+)-cyclazosin. Synthetic organic pharmaceutical agent.
(+)-HA966
(+)-HA966. Synthetic organic pharmaceutical agent.
(+)-JQ1
(+)-JQ1. Synthetic organic pharmaceutical agent.
(+)-LSD
(+)-LSD. Synthetic organic pharmaceutical agent.
(+)-MCPG
(+)-MCPG. Synthetic organic pharmaceutical agent.
(+/-)-Eriodictyol
(+/-)-Eriodictyol. Natural product pharmaceutical agent.
(12E,20Z,18S)-8-hydroxyvariabilin
(12E,20Z,18S)-8-hydroxyvariabilin. Synthetic organic pharmaceutical agent.
(1S,3R)-ACPD
(1S,3R)-ACPD. Synthetic organic pharmaceutical agent.
(2E, 6E)-farnesylbisphosphonate
(2E, 6E)-farnesylbisphosphonate. Synthetic organic pharmaceutical agent.
(2R,3R)-APDC
(2R,3R)-APDC. Synthetic organic pharmaceutical agent.
(2R,6R) 6-hydroxynorketamine
(2R,6R) 6-hydroxynorketamine. Synthetic organic pharmaceutical agent.
(2S,4S)-ketoconazole
(2S,4S)-ketoconazole. Synthetic organic pharmaceutical agent.
(2S)-2-[(6Z,15Z)-20-hydroxyicosa-6,15-dienamido]butanedioate
(2S)-2-[(6Z,15Z)-20-hydroxyicosa-6,15-dienamido]butanedioate. Synthetic organic pharmaceutical agent.
(3,5)-[19F]2-Phe-ψ-Ala
(3,5)-[19F]2-Phe-ψ-Ala. Peptide pharmaceutical agent.
(3R,4S)-293B
(3R,4S)-293B. Synthetic organic pharmaceutical agent.
(4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione
(4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione. Synthetic organic pharmaceutical agent.
(5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
(5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione. Synthetic organic pharmaceutical agent.
(5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione
(5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione. Synthetic organic pharmaceutical agent.
(5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione
(5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione. Synthetic organic pharmaceutical agent.
(B7-33)H2
(B7-33)H2. Peptide pharmaceutical agent.
(D-Ala11]bombesin
(D-Ala11]bombesin. Peptide pharmaceutical agent.
(D-Thr6, D-Trp8,9)galanin(1-15)ol
(D-Thr6, D-Trp8,9)galanin(1-15)ol. Peptide pharmaceutical agent.
(des 1-8) A-chain INSL3 analogue
(des 1-8) A-chain INSL3 analogue. Peptide pharmaceutical agent.
(E)-beta-caryophyllene
(E)-beta-caryophyllene. Natural product pharmaceutical agent.
(hydroxymethylphenyl)agomelatine
(hydroxymethylphenyl)agomelatine. Synthetic organic pharmaceutical agent.
(N)methanocarba-UTP
(N)methanocarba-UTP. Synthetic organic pharmaceutical agent.
(R,S)-4-PPG
(R,S)-4-PPG. Synthetic organic pharmaceutical agent.
(R,S)-PHPNECA
(R,S)-PHPNECA. Synthetic organic pharmaceutical agent.
(R)-α-methylhistamine
(R)-α-methylhistamine. Synthetic organic pharmaceutical agent.
(R)-ARN2508
(R)-ARN2508. Synthetic organic pharmaceutical agent.
(R)-cetirizine
(R)-cetirizine. Synthetic organic pharmaceutical agent.
(R)-DOI
(R)-DOI. Synthetic organic pharmaceutical agent.
(R)-flurbiprofen
(R)-flurbiprofen. Synthetic organic pharmaceutical agent.
(R)-flurocarazolol
(R)-flurocarazolol. Synthetic organic pharmaceutical agent.
(R)-PFI-2
(R)-PFI-2. Synthetic organic pharmaceutical agent.
(R)-SCH-23390
(R)-SCH-23390. Peptide pharmaceutical agent.